Cases & Deals

Excalibur Group acquires Merchant Ventures

Clients Merlin Biosciences Limited

Jones Day advised Excalibur Group Holdings Limited, an international investment house specializing in medical sciences and an offshoot of Merlin Biosciences, in connection with its stock-for-stock acquisition of Merchant Ventures Investment Limited.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.